Genor Biopharma (6998.HK) - Here Is Why the Stock Price Decreased by About 50%
This article analyzed the concerns of Genor Biopharma in terms of core products, competitive landscape, industry characteristics and the potential...
506 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
868 Views
Betta Pharma (č“č¾¾å»čÆ) A+H: Tier 2 Player Struggled to Break Out
The company has a comprehensive range of small molecule product candidates covering lung cancer but is short of the truly innovative drugs.
586 Views
Innovent Biologics (1801 HK) - Have the Genes to Become a Big Pharma
This article mainly analyzed Innovent in terms of its current listed products (Sintilimab, Bevacizumab, Adalimumab and Rituximab), its pipeline,...
639 Views
Pre-IPO Betta Pharmaceuticals - Insights on Products and Concerns
This article analyzed Betta Pharmaceutical in terms of its major products, pipeline, competitive landscape, and also include the concerns on the...
479 Views